D.A. Davidson & Co’s Larimar Therapeutics LRMR Stock Holding History

D.A. Davidson & Co’s Portfolio LRMR Stock Details LRMR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$32.2K	Buy	+10,550	New	+$41.9K	﹤0.01%	1577

Other funds holding LRMR

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Wealth Enhancement Advisory Services

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Cary Street Partners Richmond, Virginia $4.58B AUM 24% 1-Year Est. Return

Next Level Private Harrison, New York $511M AUM 30.94% 1-Year Est. Return

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return

Mirae Asset Global Investments

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return

D.A. Davidson & Co's LRMR Position: Q2 2026 in Review

D.A. Davidson & Co opened a new position in Larimar Therapeutics (LRMR) in Q2 2026: 10,550 shares worth $32.2K. The stake represents ﹤0.01% of the portfolio and ranks #1577 among its holdings.

19 funds tracked by Wall St. Rank hold LRMR as of Q2 2026.

D.A. Davidson & Co held 10,550 shares of Larimar Therapeutics worth $32.2K as of Q2 2026.
Larimar Therapeutics was a new D.A. Davidson & Co position in Q2 2026.
Larimar Therapeutics made up ﹤0.01% of D.A. Davidson & Co's portfolio in Q2 2026, its #1577 holding.
19 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q2 2026.

Based on D.A. Davidson & Co's 13F filing for Q2 2026, filed 24 Jul 2026.